Technology

OncoCyte

$5.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+1.49%) Today
+$0.72 (+15.13%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell OncoCyte and other stocks, options, and ETFs commission-free!

About OCX

OncoCyte Corporation, also called OncoCyte, is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA. The listed name for OCX is OncoCyte Corporation.

CEO
Ronald Asbury Andrews
Employees
33
Headquarters
Irvine, California
Founded
2009
Market Cap
281.21M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.73M
High Today
$4.91
Low Today
$4.52
Open Price
$4.58
Volume
1.91M
52 Week High
$4.92
52 Week Low
$1.15

Collections

OCX Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, After Hours

You May Also Like

VPG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure